Peter B. Silverman
DirectorMr. Peter B. Silverman, J.D, is Director of Yarrow Bioscience, Inc since July 27, 2026. Mr. Silverman is Independent Director of LeonaBio, Inc. from May 5, 2026. He was Executive Vice President and General Counsel at Merus N.V. since February 2018 and had been its Chief Intellectual Property Officer and Head of US Legal since February 2017 also served as its Interim Corporate Secretary. He served as Head of Utrecht at Merus N.V. since April 2020 until January 01, 2023. Mr. Silverman is Director of Kinaset Therapeutics, Inc. from March 2026. He had been Chief Operating Officer at Merus N.V. since January 01, 2023. His responsibilities include management of the Merus’s operations, legal and intellectual property, information technology, facilities and human resource matters and management and operations of the headquarters in Utrecht. He served as outside counsel since joining 2014 at Merus N.V. Mr. Silverman has led Merus's legal activities, including licensing, corporate, collaboration and litigation efforts and has continued to advance the Company’s intellectual property portfolio. Mr. Silverman oversees the corporate, transactional and intellectual property matters to support the Company’s scientific and organizational goals globally. Prior to joining Merus, Mr. Silverman was a Partner at Kirkland & Ellis LLP, where he represented numerous life sciences companies concerning an array of legal matters. Mr. Silverman was an associate at Kaye Scholer LLP (now Arnold White Kaye Scholer LLP). Mr. Silverman also served as judicial law clerk to U.S. District Court Judge Anne E. Thompson of the District of New Jersey. He holds a J.D. from Fordham University School of Law, graduating magna cum laude and Order of the Coif. He is admitted to practice law in New York. Mr. Silverman also holds a B.A. in biology from the University of Rochester.
Positions
- Company NameYarrow Bioscience, Inc.Stock CodeYARWPositionDirector
